Menu button
ASMBS Logo

Published June 2019

Download PDF Document

Highlighted Abstract

Introduction
Bariatric surgery for morbid obesity can help correct several comorbid conditions, including diabetes and hypertension. In most patients, this results in a reduction or discontinuation of corresponding prescription medications. As so, patients who undergo bariatric surgery should see a significant reduction in medication spending after the operation. In this study, we seek to compare the effect of bariatric surgery on the amount spent on diabetes and hypertension medications.

Methods
This study was a purely retrospective chart review. Patient data was obtained from a database retrieved by the Department of Bariatric Surgery at Rush University. The number of prescription medications for diabetes and hypertension being used prior to and after surgery was recorded. Prices were attributed to each medication based on the standardized pricing guide provided by Drugs.com. Amount spent on medications before and after surgery was calculated accordingly.

Results
Data was collected from 210 patients (F=162, M=48). Patients spent a mean of $225 on diabetes medications and $71 on hypertensive medications pre-operatively. Post-operatively, diabetes medication costs were reduced to $80 (p <.001 and at months hypertensive medication costs were reduced to months.>

Conclusions
Bariatric surgery can reduce prescription medication requirements resulting in cost savings that are not-dependent on weight loss alone. It is important for insurers, physicians, and patients to consider the potential financial impact of bariatric surgery in addition to its health benefits when deciding whether to pursue the operation.

Presenter
Naomi Parrella, MD

Affiliation
Rush Medical College

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×